Kither Biotech
PrivateLast Round
Series B
Mar 16, 2022
Total Funding Raised
$26.58M
Company Overview
Kither Biotech is a biotechnology company developing signal transduction modulators for the treatment of rare respiratory diseases such as cystic fibrosis and idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kither Biotech Comparables
Compare Kither Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterprise Therapeutics | 86% | |
| ReCode Therapeutics | 79% | |
| SpliSense | 76% | |
Kither Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 16, 2022 | ||||
| Series A | Jul 5, 2019 |
Key People
Founding team and executive leadership
Kither Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elysia Capital | Series A |
| 3B FUTURE Health Fund | Series B |
| Moschini Spa | Series A |
| Club degli Investitori | Series A, Series B |
| Claris Ventures | Series B |
| 2invest AG | Series B |
| CDP Venture Capital SGR | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 35% MoM, reaching 1K.
- Mar 16, 2022
$20.26M raised in Series B funding.
Kither Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kither Biotech's valuation, stock price, and market status.